Portegies P - Search Results

1

Low levels of specific T cell activation marker CD27 accompanied by elevated levels of markers for non-specific immune activation in the cerebrospinal fluid of patients with AIDS dementia complex.

Portegies P, Godfried MH, Hintzen RQ, Stam J, van der Poll T, Bakker M, van Deventer SJ, van Lier RA, Goudsmit J. Portegies P, et al. J Neuroimmunol. 1993 Nov-Dec;48(2):241-7. doi: 10.1016/0165-5728(93)90198-8. J Neuroimmunol. 1993. PMID: 8227320

2

Declining incidence of AIDS dementia complex after introduction of zidovudine treatment.

Portegies P, de Gans J, Lange JM, Derix MM, Speelman H, Bakker M, Danner SA, Goudsmit J. Portegies P, et al. BMJ. 1989 Sep 30;299(6703):819-21. doi: 10.1136/bmj.299.6703.819. BMJ. 1989. PMID: 2510843 Free PMC article.

3

Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies.

Kersten MJ, Evers LM, Dellemijn PL, van den Berg H, Portegies P, Hintzen RQ, van Lier RA, von dem Borne AE, van Oers RH. Kersten MJ, et al. Among authors: portegies p. Blood. 1996 Mar 1;87(5):1985-9. Blood. 1996. PMID: 8634448 Free article.

4

Cerebrospinal fluid beta2-microglobulin, monocyte chemotactic protein-1, and soluble tumour necrosis factor alpha receptors before and after treatment with lamivudine plus zidovudine or stavudine.

Enting RH, Foudraine NA, Lange JM, Jurriaans S, van der Poll T, Weverling GJ, Portegies P. Enting RH, et al. Among authors: portegies p. J Neuroimmunol. 2000 Jan 24;102(2):216-21. doi: 10.1016/s0165-5728(99)00219-2. J Neuroimmunol. 2000. PMID: 10636491 Clinical Trial.

5

Mental changes in patients with AIDS.

Derix MM, de Gans J, Stam J, Portegies P. Derix MM, et al. Among authors: portegies p. Clin Neurol Neurosurg. 1990;92(3):215-22. doi: 10.1016/0303-8467(90)90023-x. Clin Neurol Neurosurg. 1990. PMID: 2171828

6

Human immunodeficiency virus type 1 antigen in cerebrospinal fluid. Correlation with clinical neurologic status.

Portegies P, Epstein LG, Hung ST, de Gans J, Goudsmit J. Portegies P, et al. Arch Neurol. 1989 Mar;46(3):261-4. doi: 10.1001/archneur.1989.00520390027010. Arch Neurol. 1989. PMID: 2919978

7

Differences in human immunodeficiency virus type 1 V3 sequences from patients with and without AIDS dementia complex.

Kuiken CL, Goudsmit J, Weiller GF, Armstrong JS, Hartman S, Portegies P, Dekker J, Cornelissen M. Kuiken CL, et al. Among authors: portegies p. J Gen Virol. 1995 Jan;76 ( Pt 1):175-80. doi: 10.1099/0022-1317-76-1-175. J Gen Virol. 1995. PMID: 7844529

8

Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands.

Portegies P, Enting RH, de Gans J, Algra PR, Derix MM, Lange JM, Goudsmit J. Portegies P, et al. AIDS. 1993 May;7(5):669-75. AIDS. 1993. PMID: 8318174

9

Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy.

Gisolf EH, van Praag RM, Jurriaans S, Portegies P, Goudsmit J, Danner SA, Lange JM, Prins JM. Gisolf EH, et al. Among authors: portegies p. J Acquir Immune Defic Syndr. 2000 Dec 15;25(5):426-33. doi: 10.1097/00042560-200012150-00007. J Acquir Immune Defic Syndr. 2000. PMID: 11141242 Clinical Trial.

10

Kaposi's sarcoma and human herpesvirus 8 infection do not protect HIV-1 infected homosexual men from AIDS dementia complex.

Renwick N, Weverling GJ, Halaby T, Portegies P, Bakker M, Schulz TF, Goudsmit J. Renwick N, et al. Among authors: portegies p. AIDS. 2001 Nov 9;15(16):2165-9. doi: 10.1097/00002030-200111090-00012. AIDS. 2001. PMID: 11684936

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page